NL-OMON49099已完成不适用
Magnetic tracer in the sentinel node procedure in breast cancer: the non-radioactive alternative for radio-isotopes - MagTrace
Zuyderland Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •- Female patient of 18 years or older.
- •- Patient with breast cancer and indication for sentinel node procedure.
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •- Patients with a previous history of the sentinel node procedure or
- •axillary lymph node dissection in the ipsilateral breast.
- •- Hypersensitivity for ironoxide or dextran
研究者
相似试验
尚未招募
不适用
Magnetic tracer use for sentinel node biopsy: A pilot studyBreast cancerACTRN12617001368325Mr Isaac Cranshaw25
已完成
不适用
Magnetic Sentinel Node and Occult Lesion Localisation (MagSNOLL)CancerISRCTN68689512King's College London (UK)50
已完成
不适用
Magnetic versus standard technique for sentinel node biopsy in breast cancerMalignant neoplasm of breastBreast cancerCancerISRCTN20200149Guy's and St Thomas' NHS Foundation Trust924
进行中（未招募）
1 期
A randomised controlled trial comparing the standard dual technique to a novel magnetic technique for sentinel node biopsy in breast cancerEUCTR2015-000549-21-GBKing's College London99,999
终止
不适用
Magnetic Sentinel Lymph Node Mapping with FerroTrace in Breast Cancer: A Feasibility and Validity Clinical TrialCancer - BreastBreast cancerACTRN12621000687897Ferronova Pty Ltd2